Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA And CMS Push, But Questions Linger Over Unique Device Identifiers

This article was originally published in The Gray Sheet

Executive Summary

There were more questions than answers at an Oct. 25 FDA meeting to explore the creation of a unique device identifier system

You may also be interested in...



Midwest Hospitals Prepare For Stent Unique-Device-Identifier Demo

The FDA-funded effort out of the Mercy health care system, consisting of 31 hospitals and 200 outpatient facilities in Missouri, Arkansas, Oklahoma and Kansas*, is intended as a demonstration project to help troubleshoot UDIs before a mandatory nationwide system is launched. It is one of two UDI demos in the works in advance of FDA regulations.

Unique Device Identifiers Could Influence Medicare Policies – Analyst

CMS could use its 2010 proposed inpatient prospective payment system rule, expected out this month, to begin gathering public comments on the agency's role in the use of unique device identifiers, a health policy analyst says

Unique Device Identifiers Could Influence Medicare Policies – Analyst

CMS could use its 2010 proposed inpatient prospective payment system rule, expected out this month, to begin gathering public comments on the agency's role in the use of unique device identifiers, a health policy analyst says

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT024131

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel